BioRestorative Therapies (BRTX) Cash from Investing Activities (2010 - 2025)

BioRestorative Therapies (BRTX) has 12 years of Cash from Investing Activities data on file, last reported at $2.4 million in Q4 2025.

• Quarterly Cash from Investing Activities rose 56.64% year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.9 million (up 1629.25% YoY) and the FY2025 annual result came in at $8.9 million, up 1629.25% from the prior year.
• Cash from Investing Activities climbed to $2.4 million in Q4 2025, from $2.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $3.0 million in Q2 2024 to a low of -$9.9 million in Q3 2022.
• A 4-year average of -$45988.3 and a median of $877891.5 in 2023 frame the typical range for Cash from Investing Activities.
• The widest YoY moves for Cash from Investing Activities: up 4485.96% in 2024, down 294.08% in 2024.
• Tracing BRTX's Cash from Investing Activities over 4 years: stood at -$3.2 million in 2022, then soared by 97.39% to -$84798.0 in 2023, then surged by 1907.36% to $1.5 million in 2024, then surged by 56.64% to $2.4 million in 2025.
• The last three Cash from Investing Activities figures came in at $2.4 million (Q4 2025), $2.0 million (Q3 2025), and $2.1 million (Q2 2025), per Business Quant data.